Atorvastatin therapy in type 2 diabetes patients: Effects on C-reactive protein levels and cardiovascular risk [Atorvastatintherapie bei Typ-2-Diabetespatienten: Auswirkungen auf den C-reaktiven Protein-Spiegel und das kardiovaskuläre Risiko]

被引：0
|
作者：
Kahl S. [1 ]
机构：
[1] Institut für klinische Diabetologie, Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität, Leibniz-Zentrum für Diabetesforschung, Auf’m Hennekamp 65, Düsseldorf
来源：
Der Diabetologe | 2015年 / 11卷 / 4期
关键词：
D O I：
10.1007/s11428-015-1400-3
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：327 / 328
页数：1
相关论文
共 27 条
  • [21] Tirzepatide Reduces High-Sensitivity C-reactive Protein in Patients With Type 2 Diabetes and High Cardiovascular Risk: A Post Hoc Analysis of the SURPASS-4 Trial
    Bhatt, Deepak L.
    Wilson, Jonathan M.
    Wiese, Russell J.
    Yang, Zhengyu
    Duffin, Kevin L.
    Pavo, Imre
    CIRCULATION, 2023, 148
  • [22] Effect of Non-Surgical Periodontal Therapy on C-Reactive Protein, Oxidative Stress, and Matrix Metalloproteinase (MMP)-9 and MMP-2 Levels in Patients With Type 2 Diabetes: A Randomized Controlled Study
    Koromantzos, Panagiotis A.
    Makrilakis, Konstantinos
    Dereka, Xanthippi
    Offenbacher, Steven
    Katsilambros, Nicholas
    Vrotsos, Ioannis A.
    Madianos, Phoebus N.
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (01) : 3 - 10
  • [23] Procalcitonin Correlates With Cardiovascular Risk Better Than Highly Sensitive C-Reactive Protein in Patients With Type 2 Diabetes in Sub- Saharan Africa: Results From a Cross-Sectional Study
    Katte, Jean-Claude
    Kengne, Andre-Pascal
    Tchapmi, Donald
    Agoons, Batakeh B.
    Nyirenda, Moffat
    Mbacham, Wilfried
    Sobngwi, Eugene
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [24] Influence of atherosclerosis-related risk factors on serum high-sensitivity C-reactive protein levels in patients with type2 diabetes: Comparison of their influence in obese and non-obese patients
    Shimoda, Masashi
    Kaneto, Hideaki
    Yoshioka, Hiroshi
    Okauchi, Seizo
    Hirukawa, Hidenori
    Kimura, Tomohiko
    Kanda-Kimura, Yukiko
    Kohara, Kenji
    Kamei, Shinji
    Kawasaki, Fumiko
    Mune, Tomoatsu
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (02) : 197 - 205
  • [25] Comparis on of the effects of Ramipril versus Telmisartan in reducing serum levels of high-sensitivity, C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus
    Koulouris, S
    Symeonides, P
    Triantafyllou, K
    Ioannidis, G
    Karabinos, I
    Katostaras, T
    El-Ali, M
    Theodoridis, T
    Vratsista, E
    Thalassinos, N
    Kokkinou, V
    Nanas, I
    Stamatelopoulos, S
    Toutouzas, P
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11): : 1386 - 1388
  • [26] Modulatory Effects of NBF1, an Algal Fiber-Rich Bioformula, on Adiponectin and C-Reactive Protein Levels, and Its Therapeutic Prospects for Metabolic Syndrome and Type-2 Diabetes Patients
    Ngatu, Nlandu Roger
    Ikeda, Mitsunori
    Tonduangu, Daniel Kuezina
    Nangana, Severin Luzitu
    Hirao, Tomohiro
    BIOMEDICINES, 2022, 10 (10)
  • [27] Serum High-Sensitivity C-Reactive Protein Levels Are Associated With High Risk of Development, Not Progression, of Diabetic Nephropathy Among Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT7])
    Hayashino, Yasuaki
    Mashitani, Tsuyoshi
    Tsujii, Satoru
    Ishii, Hitoshi
    DIABETES CARE, 2014, 37 (11) : 2947 - 2952
123